![]() | ![]() |
Formats:
|
||||||||||||||
Copyright © 2006 by The National Academy of Sciences of the USA Genetics Genes with internal repeats require the THO complex for transcription *Whitehead Institute for Biomedical Research, Nine Cambridge Center, Cambridge, MA 02142; †Department of Biology, Massachusetts Institute of Technology, Cambridge, MA 02139; ‡Bauer Center for Genomics Research, Harvard University, 7 Divinity Avenue, Cambridge, MA 02138; §Department of Microbial and Molecular Systems, Faculty of Bioscience Engineering, Katholieke Universiteit Leuven, Kasteelpark Arenberg 22, B-3001 Leuven, Belgium; ¶Department of Biological Chemistry and Molecular Pharmacology, Harvard Medical School, 240 Longwood Avenue, Boston, MA 02115 ‖To whom correspondence should be addressed. E-mail: gfink/at/wi.mit.edu Contributed by Gerald R. Fink, August 1, 2006 .Author contributions: V.V., K.J.V., S.B., and G.R.F. designed research; V.V., A.J., and V.M.R. performed research; V.V., K.J.V., A.J., V.M.R., and S.B. contributed new reagents/analytic tools; V.V., V.M.R., S.B., and G.R.F. analyzed data; and V.V. and G.R.F. wrote the paper. This article has been cited by other articles in PMC.Abstract The evolutionarily conserved multisubunit THO complex, which is recruited to actively transcribed genes, is required for the efficient expression of FLO11 and other yeast genes that have long internal tandem repeats. FLO11 transcription elongation in Tho− mutants is hindered in the region of the tandem repeats, resulting in a loss of function. Moreover, the repeats become genetically unstable in Tho− mutants. A FLO11 gene without the tandem repeats is transcribed equally well in Tho+ or Tho− strains. The Tho− defect in transcription is suppressed by overexpression of topoisomerase I, suggesting that the THO complex functions to rectify aberrant structures that arise during transcription. Keywords: adhesion, Hpr1, Thp2, topoisomerase I Transcription involves a highly orchestrated series of events in which the core polymerase is joined by many additional proteins that promote initiation, elongation, and termination (1–3). Efficient transcription also depends on the configuration of the DNA template because transcription creates negative supercoils behind the polymerase and positive supercoils ahead of it (4–6). These alterations in the superhelical density could permit repetitive sequences to form structures that impede the progress of the polymerase and promote recombination. For example, excessive supercoiling in yeast leads to hyperrecombination at the highly repetitive rRNA-encoding DNA locus (7, 8). The DNA landscape may therefore influence the efficiency of transcription, and some of the elongation factors could be required to remodel the template to permit efficient transcription. The Saccharomyces cerevisiae multisubunit THO complex, which has been identified as a possible elongation component, has been associated with many aspects of RNA and DNA metabolism (9–12). The complex consists of four tightly bound proteins (Hpr1, Tho2, Thp1, and Mft1) (13), two of which (Hpr1 and Tho2) are conserved from yeast to humans (14). Biochemical studies using natural templates have implicated the THO complex in recruiting the mRNA export proteins Sub2 (UAP56 in humans) and Yra1 (Aly1) to the mRNA in both yeast (15) and humans (14). In yeast, ChIP immunoprecipitation experiments indicate that the THO complex is recruited to actively transcribed genes (16–18). The biochemical analysis of the function of the THO complex has not led to a consistent picture. Experiments using a GAL1 promoted Escherichia coli lacZ reporter construct expressed in yeast suggested that transcription elongation of the lacZ gene is reduced in an hpr1Δ mutant (19). Further analysis using a PGAL-lacZ system indicated that in a Tho− mutant DNA:RNA hybrids are formed in vivo between the nascent transcript and the DNA template (20). Because the transcription of GC-rich lacZ constructs was THO-dependent, whereas that of many endogenous yeast genes was not, it was proposed that the THO complex is required for efficient transcription elongation of long and GC-rich genes (21). Moreover, the role of the THO complex in elongation has been questioned based on the insensitivity of Tho− mutants to mycophenolic acid, a presumed inhibitor of transcription elongation (22). Remarkably, the genetic analysis of Tho− mutants has not resolved these puzzles and has provided little information on native genes that require THO complex function. Mutations in any of the four genes encoding the THO complex subunits do not result in inviability at normal growth conditions, suggesting that the THO proteins are not a core component of the elongation complex. However, one class of Tho− mutants [hyperrecombination 1 (hpr1)] was first identified because a mutation in that gene increases the frequency of recombination between artificial tandem repeats constructed by transformation (23). Sequence similarity between Hpr1 and the topoisomerase Top1 as well as the lethality of top1Δ hpr1Δ double mutants (23, 24) are likely to reflect functional redundancy with respect to DNA metabolism. In Drosophila, loss of THO complex function results in only minor differences in transcription profiles as revealed by whole genome arrays (25). In both Drosophila and yeast, the apparent participation of the THO complex in some aspects of transcription and recombination contrasts with the absence of an effect of Tho− mutations on resident genes. In this report, we show that THO function is required for the transcription of several resident yeast genes containing multiple internal tandem repeats. The affected genes are not especially long, and neither the genes nor the repeats are GC-rich. The defect in transcription appears to be in transcription elongation, based on ChIP experiments designed to reveal RNA polymerase occupancy. Transcription is restored in Tho− mutants when the repeats are removed from the gene. Because whole genome arrays comparing Tho+ and Tho− strains do not reveal any general defects in transcription, these effects appear to be restricted to a subset of genes with internal repeats. The fact that the transcriptional defects in Tho− mutants can be suppressed by overexpression of TOP1 suggests a model in which the THO complex functions as an accessory complex that facilitates transcription past obstructive DNA configurations. Results FLO11-Dependent Adhesion Requires the THO Complex. The gene knockout library of S. cerevisiae containing all viable single-gene deletions was screened to identify genes that are required for FLO11 function. FLO11, a gene with many long internal tandem repeats, confers adhesion of cells to inert substrates, such as agar (26, 27). The screen used a PTEFFLO11 construct in which the FLO11 gene was transcribed from the constitutive TEF promoter. This construct confers adherence to solid agar in S288c strains (Fig. 1
The nonadherent phenotype of the Tho− mutants is independent of the strain background and the promoter. Each member of the THO complex, THP2, MFT1, HPR1, and THO2, was separately deleted in a Σ1278b strain in which FLO11 is under its native promoter at its resident site in the chromosome. Each of the four Tho− mutants also is strongly nonadherent in this background (Fig. 1 Reduction of FLO11 mRNA Levels in Tho− Mutants Requires the FLO11 Coding Sequence. FLO11 mRNA analysis by Northern blots as well as by real-time PCR (rtPCR) shows that thp2Δ and mft1Δ mutants have reduced levels of FLO11 mRNA as compared with Tho+ strains (Fig. 1 FLO11 Requires the THO Complex for Transcription Elongation Through the Repeats. RNA polymerase (RNAP) II occupancy along the FLO11 ORF was monitored in Tho+ and Tho− strains by ChIP using an antibody to the Rpb3 subunit of the polymerase. The amount of FLO11 DNA in the precipitate was assessed by PCR amplification. FLO11 is an ORF of 4,104 nt, the middle third of which features 15 nearly perfect tandem repeats of 1,725 nt total length (28). We designed six primer pairs along FLO11: one in the promoter region, two in the 5′-end proximal region, two in the 3′end region, and one in the 3′ UTR (Fig. 2
To examine the role of the FLO11 repeats on transcription, we constructed a FLO11 allele that lacks the repeat-containing region (flo11::Δrep) and compared the levels of FLO11 transcription in Tho+ and mft1Δ thp2Δ strains. FLO11 expression is at least 65% reduced in mft1Δ thp2Δ compared with the wild-type strain, whereas flo11::Δrep expression in the mutant strain is nearly the same as that in Tho+ (Fig. 2 The obstacle to transcription caused by the repeats in a Tho− mutant has a profound consequence on the genetic stability of the repeats. The stability of the repetitive region was measured in a FLO11::URA3 genomic construct that contains the URA3 gene inserted among the FLO11 repeats (Fig. 2 Other Genes with Repeats Require the THO Complex for Efficient Transcription. TIR1 is a cell wall gene encoded by 765 nt, 261 of which are internal tandem repeats. The gene is required for hypoxic growth and is induced by cold shock as well as by low oxygen levels (29). The level of TIR1 mRNA was measured in a Tho+ strain and in Tho− mutants after a 90-min cold shock at 15°C. There is an ≈50% reduction of TIR1 expression in mft1Δ and thp2Δ and >75% reduction in hpr1Δ and tho2Δ mutants (Fig. 3
The expression of FLO1, another gene with long tandem repeats, also is reduced in Tho− mutants (Fig. 3 For comparison, we also measured the mRNA levels of several ORFs without internal repeats of various lengths and expression levels: PMA1 (2,757 nt) and TEF1 (1,377 nt), which are highly expressed genes, and LYS2 (4,179 nt), a gene expressed at lower levels. Expression of all three genes is unaffected in the mft1Δ thp2Δ mutant (Fig. 3 Intragenic Repeats Confer THO Dependence. An in-frame segment containing three FLO1 repeats (a total of 414 nt) was inserted into the LYS2 gene to test the effect of these repeats on transcription of that gene (Fig. 4
Overexpression of TOP1 Suppresses the Tho− Defect. The partial homology between Hpr1 and Top1 (23) and the lethality of hpr1Δ top1Δ or mft1Δ top1Δ double mutants suggested an overlap between topoisomerase and THO complex function. To test this possibility, we constructed a Tho− strain and a Tho+ strain that contained the TOP1 gene under the highly expressed TEF promoter and compared these strains with Tho− and Tho+ strains without the overexpression construct. TOP1 overexpression in Tho− mutants partially restores FLO11 mRNA levels (Fig. 5
Discussion The yeast genes affected by mutation of the THO complex have a number of similarities. The most salient attribute is that they are genes with many long tandem internal repeats. Genes with long internal tandem repeats are not a feature restricted to the yeast genome. It is estimated that 5% of human genes also have tandem repeats (30). As we showed previously (28), most of the yeast genes with internal repeats encode cell wall proteins, and the repeats are essential for cell surface interactions, such as adhesion. Here we show that alleles of genes with internal repeats require the THO complex for maximum expression and are genetically unstable in Tho− mutants. Our data showing that overexpression of topoisomerase I suppresses the Tho− defect in FLO11 transcription further implicates the THO complex in DNA topology. Although several previous studies using recombinant constructs have suggested that the THO complex was required either for genes of high GC content or for especially long genes, the yeast genes whose expression is dramatically affected do not have a high GC content [FLO11 46% (50% for the region of repeats)] (Table 1). The FLO11 and FLO1 genes are longer than the average yeast gene; however, transcription of yeast genes of equivalent size (RPB1 and LYS2) is unaffected in Tho− mutants under standard growth conditions, and a third THO-dependent gene, TIR1, is only 765 nt long. Moreover, in a Tho+ strain there is little difference between the expression of the long (4.1 kb) or short (2.5 kb) form of the FLO11 gene. However, efficient transcription of the wild-type FLO11 gene containing the repeats depends on a functional THO complex, whereas a FLO11 gene without the repeats (flo11::Δrep) is expressed at the same level in both Tho+ and Tho− strains. The presumed importance of the THO complex for maintaining the topology of the DNA template contrasts with the failure of previous studies to identify phenotypic effects of Tho− mutants on native genes. In addition, we failed to detect any dramatic global change in the level of transcription for most genes as measured by whole genome microarrays in yeast. A similar analysis in D. melanogaster concluded that “the vast majority of genes are transcribed and exported independently of THO” (25). We posit that for most genes the activity of Top1 is sufficient to prevent the topological impediments to transcription elongation. However, for genes that have repeated obstructive sequences, such as the FLO genes, the stress on the system overwhelms the ability of Top1 to correct the defect. Under these conditions, the THO complex becomes essential. This view raises the question of whether the THO complex is required only for efficient transcription of genes with long tandem repeats, which we think is unlikely. First, not all genes with tandem repeats show a phenotype in the Tho− strains (Table 1). Of course, many of these genes with repeats are expressed at extremely low levels and may, like TIR1, only require the THO complex upon induction or some environmental stress condition that requires enhanced transcription. Second, other genes whose transcription creates aberrant structures under stress conditions could also require the THO complex. For example, DNA:RNA hybrids, or R loops, have been detected during transcription in Tho− mutants (20), and increased levels of recombination have been associated with R-loop formation in Topo− (6, 31) as well as in splicing mutants (32). It is in this sense that we posit the THO complex as a protein complex whose function is to repattern the transcription complex, permitting efficient transcription elongation when transcription stalls. Materials and Methods Yeast Strains and Growth Conditions. Strains in two genetic backgrounds, S288c and Σ1278b, were used in these studies (Table 2, which is published as supporting information on the PNAS web site). The deletion library is in the S288c background, which has a mutation in the flo8 gene (33). Because FLO8 encodes a transcription factor required for FLO11 expression, the screen of the library for mutations that caused the Flo− phenotype was performed with a PTEFFLO11 construct. This construct not only permits the screen of the S288c deletion library but also reports FLO11 promoter-independent transacting mutations. Each of the Tho− mutants is a complete deletion of the respective THO gene. After the Tho− mutants were identified in the S288c screen, each was transformed into the Σ1278b 10560-23C strain and found to have a similar nonadherent phenotype. For the yeast deletion library transformation, mutant strains in 96-well plates were preincubated with the URA3/CEN PTEFFLO11 plasmid B4126 and standard PEG/LiOAc/TE/ssDNA mixture (where TE is 10 mM Tris/1 mM EDTA, pH 7.5) for 3 h at 30°C, followed by a 45-min heat shock at 42°C. Transformants were grown on synthetic complete media (SC) lacking Ura, with the media first as a liquid (3 days) and then as a solid (2 days). A pool of transformants for each mutant was patched on a yeast extract/peptone/dextrose (YPD) rectangular plate and tested for adhesion after 1 day of growth at 30°C by a gentle wash under running water. The S288c FLO8+ strain L8046 was prepared by transforming a pRS305-based BglII-cut integrating plasmid that contains a Σ1278b copy of FLO8 (B4241) into the S288c flo8− strain L4242. Strains with a FLO11 allele that lacks the repeats region, flo11::Δrep, were constructed in two steps. First, the URA3 marker was amplified from a plasmid with primers V271 and V272 targeting the ends of the FLO11 repeats region. Second, these FLO11::URA3 strains were streaked on plates containing 5-fluoroorotic acid to loop out the URA3 marker. The LYS2+3rep strain that has three FLO1 repeats inserted at position 720 nt of LYS2 was prepared in the following way. A FLO1rep–URA3–FLO1rep cassette was amplified from the genomic DNA of strain KV133 (28) with primers K428 and K429 to create overhangs for in-frame integration at LYS2 in the strain BY4741. Transformants that were Ura+ and Lys− were then streaked on SC plus 5-fluoroorotic acid or SC-Lys plates to force URA3 popouts, leaving behind FLO1 repeats in LYS2. The LYS2+3rep chimera construct was confirmed by sequencing. Strains were grown in YPD, unless selective media were required. Cold shock and anaerobic growth experiments were based on previously described protocols (29). For cold shock, cultures were grown at 30°C to OD600 1.0 and then shifted to 15°C for 90 min; strains were grown hypoxically on YPD plates supplemented with 0.5% Tween 80 and 20 μg/ml ergosterol (Sigma, St. Louis, MO) and placed in a hypoxic chamber with an AnaeroPack sachet (Mitsubishi Gas Chemical America, New York, NY) for 3 days at 30°C. A Bioscreen apparatus (Labsystems, Chicago, IL) was used for the growth comparison of LYS2+3rep strains. Several reagents were used for selection or counterselection during the preparation of strains: 0.2 mg/ml geneticin (GIBCO, Carlsbad, CA), 0.3 mg/ml hygromycin (Sigma), 0.1 mg/ml nourseothricin (Werner BioAgents, Jena, Germany), and 1 mg/ml 5-fluoroorotic acid (USBiological, Swampscott, MA). The frequency of Ura− segregants of FLO11::URA3 Tho+ (XY266) or thp2Δ (XY454) strains was determined after growth on YPD plates for 1 day at 30°C, followed by plating on SC plus 5-fluoroorotic acid to count colony-forming units. Primers and Plasmid Construction. Primers are listed in Table 3, which is published as supporting information on the PNAS web site. Primer pairs for rtPCR analysis were designed with Primer Express software. The primer pairs along FLO11 for ChIP analysis were designed to yield products of 250–300 bp. Primers for amplification of an untranscribed region on chromosome V were as previously described (34). The plasmid B4126 was constructed by transferring a StuI/AgeI fragment that contains FLO11 from B4050 (35) into a p416TEF CEN plasmid linearized with EcoRI and XhoI. mRNA Analysis. Total RNA was isolated from 10-ml cultures grown to an OD600 of 1.0 by using hot acid phenol. DNaseI treatment was carried out for 30 min (Epicentre Biotechnologies, Madison, WI). Reverse transcription of 0.3 μg of RNA was performed for 30 min at 48°C with 12.5 units of MultiScribe reverse transcriptase (Applied Biosystems, Framingham, MA) and 2.5 μM random hexamers. One-seventh of the cDNA product was used for rtPCR analysis with reagents from Applied Biosystems and the ABI 7500 rtPCR system. Probes at the 3′ end of ORFs were used when available. Normalization was to ACT1, except when analyzing Σ1278b Tho− mutants, where we noticed a slight up-regulation of ACT1 in Tho− mutants compared with other controls. In those cases, normalization was to SCR1, a gene transcribed by RNAP III. The histograms present data from two to four independent experiments. Northern hybridization was performed on 10-μg RNA samples after gel electrophoresis. The blots were first hybridized with a FLO11 probe and then with an SCR1 probe. ChIP. ChIP were performed as previously described (34). Briefly, cells were grown to an OD600 of 0.8–1.0, fixed with formaldehyde, lysed, and sonicated. The lysates were immunoprecipitated with an anti-Rpb3 antibody (NeoClone, Madison, WI) bound to Protein G Sepharose beads (Amersham Biosciences, Piscataway, NJ). Overnight incubation at 4°C was followed by four washes. The protein/DNA complexes were eluted, and the cross-links were reversed with pronase (Calbiochem, San Diego, CA). DNA was analyzed by concurrent PCR of a FLO11 region and an untranscribed region on chromosome V. All samples were resolved on a 6% polyacrylamide gel, and the signals were quantitated by a PhosphorImager and ImageQuant software. Occupancy value for each of six regions along FLO11 was calculated as a ratio (immunoprecipitation sample/input sample) of ratios (FLO11 specific signal/untranscribed region signal). The ChIP assays were performed both on strains in the S288c and Σ1278b backgrounds. Although there were quantitative differences in the relative enrichment of both backgrounds, the polymerase occupancy in the Tho− strains was reduced in the 3′ end of the FLO11 strain. Better enrichment of the specific signal in the immunoprecipitation sample was observed for S288c than for Σ1278b strains. Bioinformatics. The GC content of DNA sequences was determined with EMBOSS GEECEE software. Supporting Information
Acknowledgments We thank Phil Sharp, Rob Wheeler, and Claire Tseng for critical reading of the manuscript; members of the G.R.F. laboratory for discussions and reagents; Milan de Vries for the large-scale transformation protocol; the laboratory of Susan Lindquist (Whitehead Institute for Biomedical Research/Massachusetts Institute of Technology) for use of the Bioscreen machine; George Bell and Kim Walker for help with bioinformatics; and Tom DiCesare for help with graphics. K.J.V. acknowledges financial support from the Harvard University Bauer Center, the Belgian American Educational Foundation, and from the Fund for Scientific Research–Flanders (Belgium). This work was supported by National Institutes of Health Grants GM56663 (to S.B.) and GM35010 (to G.R.F.). G.R.F. is an American Cancer Society Professor. Footnotes The authors declare no conflict of interest. References 1. Lee TI, Young RA. Annu Rev Genet. 2000;34:77–137. [PubMed] 2. Maniatis T, Reed R. Nature. 2002;416:499–506. [PubMed] 3. Arndt KM, Kane CM. Trends Genet. 2003;19:543–550. [PubMed] 4. Liu LF, Wang JC. Proc Natl Acad Sci USA. 1987;84:7024–7027. [PubMed] 5. Brill SJ, Sternglanz R. Cell. 1988;54:403–411. [PubMed] 6. Drolet M. Mol Microbiol. 2006;59:723–730. [PubMed] 7. Christman MF, Dietrich FS, Fink GR. Cell. 1988;55:413–425. [PubMed] 8. Kim RA, Wang JC. Cell. 1989;57:975–985. [PubMed] 9. Fan HY, Cheng KK, Klein HL. Genetics. 1996;142:749–759. [PubMed] 10. Prado F, Piruat JI, Aguilera A. EMBO J. 1997;16:2826–2835. [PubMed] 11. Fan HY, Merker RJ, Klein HL. Mol Cell Biol. 2001;21:5459–5470. [PubMed] 12. Jimeno S, Rondon AG, Luna R, Aguilera A. EMBO J. 2002;21:3526–3535. [PubMed] 13. Chavez S, Beilharz T, Rondon A, Erdjument-Bromage H, Tempst P, Svejstrup J, Lithgow T, Aguilera A. EMBO J. 2000;19:5824–5834. [PubMed] 14. Reed R, Cheng H. Curr Opin Cell Biol. 2005;17:269–273. [PubMed] 15. Zenklusen D, Vinciguerra P, Wyss JC, Stutz F. Mol Cell Biol. 2002;22:8241–8253. [PubMed] 16. Strasser K, Masuda S, Mason P, Pfannstiel J, Oppizzi M, Rodriguez-Navarro S, Rondon AG, Aguilera A, Struhl K, Reed R, Hurt E. Nature. 2002;417:304–308. [PubMed] 17. Abruzzi K, Lacadie S, Rosbash M. EMBO J. 2004;23:2620–2631. [PubMed] 18. Kim M, Ahn SH, Krogan NJ, Greenblatt JF, Buratowski S. EMBO J. 2004;23:354–364. [PubMed] 19. Chavez S, Aguilera A. Genes Dev. 1997;11:3459–3470. [PubMed] 20. Huertas P, Aguilera A. Mol Cell. 2003;12:711–721. [PubMed] 21. Chavez S, Garcia-Rubio M, Prado F, Aguilera A. Mol Cell Biol. 2001;21:7054–7064. [PubMed] 22. Jensen T, Boulay J, Olesen J, Colin J, Weyler M, Libri D. Mol Cell. 2004;16:235–244. [PubMed] 23. Aguilera A, Klein H. Mol Cell Biol. 1990;10:1439–1451. [PubMed] 24. Sadoff B, Heath-Pagliuso S, Castano I, Zhu Y, Kieff F, Christman M. Genetics. 1995;141:465–479. [PubMed] 25. Rehwinkel J, Herold A, Gari K, Kocher T, Rode M, Ciccarelli F, Wilm M, Izaurralde E. Nat Struct Mol Biol. 2004;11:558–566. [PubMed] 26. Roberts RL, Fink GR. Genes Dev. 1994;8:2974–2985. [PubMed] 27. Lambrechts MG, Bauer FF, Marmur J, Pretorius IS. Proc Natl Acad Sci USA. 1996;93:8419–8424. [PubMed] 28. Verstrepen K, Jansen A, Lewitter F, Fink G. Nat Genet. 2005;37:986–990. [PubMed] 29. Abramova N, Sertil O, Mehta S, Lowry C. J Bacteriol. 2001;183:2881–2887. [PubMed] 30. O'Dushlaine CT, Edwards RJ, Park SD, Shields DC. Genome Biol. 2005;6:R69. [PubMed] 31. Masse E, Drolet M. J Biol Chem. 1999;274:16659–16664. [PubMed] 32. Li X, Manley J. Cell. 2005;122:365–378. [PubMed] 33. Liu H, Styles C, Fink G. Genetics. 1996;144:967–978. [PubMed] 34. Keogh M, Buratowski S. Methods Mol Biol. 2004;2557:1–16. [PubMed] 35. Guo B, Styles C, Feng Q, Fink G. Proc Natl Acad Sci USA. 2000;97:12158–12163. [PubMed] |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||
Annu Rev Genet. 2000; 34():77-137.
[Annu Rev Genet. 2000]Nature. 2002 Apr 4; 416(6880):499-506.
[Nature. 2002]Trends Genet. 2003 Oct; 19(10):543-50.
[Trends Genet. 2003]Proc Natl Acad Sci U S A. 1987 Oct; 84(20):7024-7.
[Proc Natl Acad Sci U S A. 1987]Cell. 1988 Jul 29; 54(3):403-11.
[Cell. 1988]Genetics. 1996 Mar; 142(3):749-59.
[Genetics. 1996]EMBO J. 1997 May 15; 16(10):2826-35.
[EMBO J. 1997]Mol Cell Biol. 2001 Aug; 21(16):5459-70.
[Mol Cell Biol. 2001]EMBO J. 2002 Jul 1; 21(13):3526-35.
[EMBO J. 2002]EMBO J. 2000 Nov 1; 19(21):5824-34.
[EMBO J. 2000]Genes Dev. 1997 Dec 15; 11(24):3459-70.
[Genes Dev. 1997]Mol Cell. 2003 Sep; 12(3):711-21.
[Mol Cell. 2003]Mol Cell Biol. 2001 Oct; 21(20):7054-64.
[Mol Cell Biol. 2001]Mol Cell. 2004 Oct 22; 16(2):235-44.
[Mol Cell. 2004]Mol Cell Biol. 1990 Apr; 10(4):1439-51.
[Mol Cell Biol. 1990]Genetics. 1995 Oct; 141(2):465-79.
[Genetics. 1995]Nat Struct Mol Biol. 2004 Jun; 11(6):558-66.
[Nat Struct Mol Biol. 2004]Genes Dev. 1994 Dec 15; 8(24):2974-85.
[Genes Dev. 1994]Proc Natl Acad Sci U S A. 1996 Aug 6; 93(16):8419-24.
[Proc Natl Acad Sci U S A. 1996]Nat Genet. 2005 Sep; 37(9):986-90.
[Nat Genet. 2005]Nat Genet. 2005 Sep; 37(9):986-90.
[Nat Genet. 2005]J Bacteriol. 2001 May; 183(9):2881-7.
[J Bacteriol. 2001]Mol Cell Biol. 1990 Apr; 10(4):1439-51.
[Mol Cell Biol. 1990]Genome Biol. 2005; 6(8):R69.
[Genome Biol. 2005]Nat Genet. 2005 Sep; 37(9):986-90.
[Nat Genet. 2005]Nat Struct Mol Biol. 2004 Jun; 11(6):558-66.
[Nat Struct Mol Biol. 2004]Mol Cell. 2003 Sep; 12(3):711-21.
[Mol Cell. 2003]Mol Microbiol. 2006 Feb; 59(3):723-30.
[Mol Microbiol. 2006]J Biol Chem. 1999 Jun 4; 274(23):16659-64.
[J Biol Chem. 1999]Cell. 2005 Aug 12; 122(3):365-78.
[Cell. 2005]Genetics. 1996 Nov; 144(3):967-78.
[Genetics. 1996]Nat Genet. 2005 Sep; 37(9):986-90.
[Nat Genet. 2005]J Bacteriol. 2001 May; 183(9):2881-7.
[J Bacteriol. 2001]Methods Mol Biol. 2004; 257():1-16.
[Methods Mol Biol. 2004]Proc Natl Acad Sci U S A. 2000 Oct 24; 97(22):12158-63.
[Proc Natl Acad Sci U S A. 2000]Methods Mol Biol. 2004; 257():1-16.
[Methods Mol Biol. 2004]